SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019456
Filing Date
2018-08-06
Accepted
2018-08-06 16:33:17
Documents
53
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fate-10q_20180630.htm 10-Q 1406845
2 EX-10.1 fate-ex101_80.htm EX-10.1 173040
3 EX-10.2 fate-ex102_223.htm EX-10.2 522806
4 EX-31.1 fate-ex311_6.htm EX-31.1 9830
5 EX-32.1 fate-ex321_7.htm EX-32.1 4811
6 GRAPHIC gebp5rm3spaf000001.jpg GRAPHIC 40735
7 GRAPHIC gebp5rm3spaf000013.jpg GRAPHIC 9584
  Complete submission text file 0001564590-18-019456.txt   6030029

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT fate-20180630.xml EX-101.INS 993286
9 XBRL TAXONOMY EXTENSION SCHEMA fate-20180630.xsd EX-101.SCH 50956
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20180630_cal.xml EX-101.CAL 41812
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20180630_def.xml EX-101.DEF 198897
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20180630_lab.xml EX-101.LAB 379497
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20180630_pre.xml EX-101.PRE 286035
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 18995176
SIC: 2836 Biological Products, (No Diagnostic Substances)